Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4517 USD | -1.05% | -4.06% | -69.06% |
06/05 | Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib | MT |
06/05 | RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
-69.06% | 14.55M | |
-2.95% | 90.75B | |
-4.34% | 39.03B | |
-17.09% | 31.85B | |
+61.22% | 26.26B | |
-22.15% | 14.13B | |
-9.60% | 12.87B | |
-11.39% | 11.6B | |
-46.06% | 10.91B | |
+2.17% | 8.89B |
- Stock Market
- Equities
- RDHL Stock
- News RedHill Biopharma Ltd.
- Transcript : RedHill Biopharma Ltd., Q2 2020 Earnings Call, Aug 13, 2020